HCA
BCYC

Harbor Capital Advisors’s Bicycle Therapeutics BCYC Stock Holding History

Harbor Capital Advisors’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,486
Closed -$287K – 1246
2025
Q4 		$287K Sell
40,486
-882
-2% -$6.5K 0.02% 581
2025
Q3 		$320K Sell
41,368
-97,293
-70% -$734K 0.02% 564
2025
Q2 		$964K Sell
138,661
-9,468
-6% -$75.4K 0.04% 440
2025
Q1 		$1.26M Buy
148,129
+16,624
+13% +$196K 0.06% 385
2024
Q4 		$1.84M Sell
131,505
-2,202
-2% -$47.2K 0.08% 312
2024
Q3 		$3.03M Buy
133,707
+78,418
+142% +$1.81M 0.13% 223
2024
Q2 		$1.12M Buy
55,289
+11,809
+27% +$267K 0.09% 327
2024
Q1 		$1.08M Buy
43,480
+16,792
+63% +$357K 0.14% 192
2023
Q4 		$483K Buy
26,688
+2,478
+10% +$41K 0.09% 245
2023
Q3 		$486K Buy
24,210
+3,165
+15% +$72.4K 0.1% 232
2023
Q2 		$537K Buy
21,045
+1,913
+10% +$44.4K 0.11% 233
2023
Q1 		$407K Sell
19,132
-5,015
-21% -$126K 0.12% 159
2022
Q4 		$715K Sell
24,147
-21,520
-47% -$577K 0.69% 53
2022
Q3 		$1.06M Sell
45,667
-5,360
-11% -$128K 0.98% 31
2022
Q2 		$856K Buy
51,027
+22,085
+76% +$466K 0.65% 49
2022
Q1 		$1.27M Sell
28,942
-5,658
-16% -$264K 0.6% 52
2021
Q4 		$2.11M Buy
+34,600
New +$1.91M 0.77% 43

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Harbor Capital Advisors's BCYC Position: Q1 2026 in Review

Harbor Capital Advisors sold out of Bicycle Therapeutics (BCYC) in Q1 2026, closing a stake of 40,486 shares — an estimated $287K sold.

Harbor Capital Advisors first reported a position in BCYC in Q4 2021 and held it in 17 quarters. The position peaked at $3.03M in Q3 2024. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Harbor Capital Advisors reported no remaining Bicycle Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Harbor Capital Advisors sold 40,486 Bicycle Therapeutics shares in Q1 2026, an estimated $287K.
  • Harbor Capital Advisors first reported a position in Bicycle Therapeutics in Q4 2021 and held it in 17 quarters.
  • Harbor Capital Advisors's Bicycle Therapeutics position peaked at $3.03M in Q3 2024.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.